T he U.S. Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), Wildlife Services (WS) program is the federal program that provides leadership in managing problems that occur when human activity and wildlife are in conflict (1, 2) . Human conflicts with avian species are numerous. Birds depredate food crops as well as present public health and aviation safety concerns. The National Wildlife Research Center (NWRC) devotes significant resources in developing nonlethal approaches to wildlife management. Cholesterol inhibition is one such nonlethal approach being investigated for control of pest bird populations. As cholesterol is a precursor for reproductive hormones, we are evaluating the effects of feeding the cholesterol analog DiazaCon (azacosterol, omitrol, 20,25 diazacholesterol, diazasterol; Figure I ) on reproductive success in Cotumix quail (Cotumix cotumix). If DiazaCon reduces the levels of cholesterol available for hormone synthesis, reproductive success will likely diminish. The effects of DiazaCon administration on avian reproduction were previously investigated in red-wing blackbirds ( 3 4 , pigeons (7, 8) , house sparrows Received July 28, 1999. Accepted by W! 3B August I, 2Wo. (9, 10) . grackles (6) , and Japanese quail and parakeets (11) . Unfortunately, the results of these studies are conflicting.
To increase the likelihood of success, Coltumix quail, a species that readily reproduces under laboratory conditions (12. 13), were used as the test species. Quail were fed acholesterol free diet containing 0.1% DiazaCon for 14 days. With this design, the effects of 20,25 diazacholesterol inhibition on reproduction can be easily discerned. In previous studies, DiazaCon feed levels lower than 0.1% were found to be ineffective while higher levels produced mild toxic symptoms (14, 15) . Efficacy (decreased laying) was noted after a minimum of 5 days of feeding, but feeding was not recommended for greater than 16 days (15) . To better understand the mechanism(s) of efficacy, blood levels of DiazaCon, cholesterol, testosterone, and progesterone were monitored weekly.
Due to the lack of published analytical methodology, methods for the quantitation of DiazaCon in feed and sera needed to be developed. Our initial approach of adapting published methods for quantitating of cholesterol in blood (1619) were unsuccessful, apparently due to the ionic nature of DiazaCon as compared to cholesterol. To permit chromatographic separation and subsequent quantitation of the DiazaCon, we formed an ion pair with hepatanesulfonic acid and DiazaCon before analysis via an ion pair reversed-phase liquid chromatographic (LC) system. 
METHOD

Reagents
Sample Analysis
Prior to the LC analysis of sample extracts, confum system suitability with consecutive injections of working standard solution to achieve a standard deviation for chromatographic area response 52%. To confirm response linearity, inject linearity standards in duplicate. Perform a linear regression analysis on the resulting mean chromatographic response vs concentration data to determine ? (coefficient of detenninationj.
To determine proportionality of chromatographic response, perform linear regression analysis on a log-log plot of these variables. To assess coextracted potential chromatographic interferences, analyze extracts of nonfortified control matrixes. Using the chromatograms from a control extract and the extract from a control feed or serum sample fortified at 500 pglg or 40 pg/mL, respectively, calculate the method limit of detection (MLOD) as the concentration in a standard which would generate a response equivalent to 3 times the chromatographic response at the retention time of DiazaCon in the control chromatogram. At the end of the analysis day, columns are eluted with ca 60 mL column washing solution.
Chromatographic peak area is used to calculate the concentration of DiazaCon in sera as follows: 
Csfd (wgImL) -As sample wt (g) 1 x lo6 pg where Au = DiazaCon chromatographic response for sample; As = DiazaCon chromatographic response for working standard solution; and Cstd = DiazaCon concentration in working standard solution.
Results and Discussion
As the DiazaCon analytical standard had been synthesized approximately 10 years prior to beginning the work reported here, purity was determined by elemental analysis, melting point analysis, mass spectrometry (MS), and nuclear magnetic resonance spectroscopy. Elemental analysis (CHN) was conducted by Desert Analytics (Tucson, AZ). Analytical results for percent C, H, and N of 77.3, 11.45, and 7.14%, respectively, were nearly identical to the theoretical values of 77.26, 11.41, and 7.20%. The observed melting point was 147'C (lit = 146°-1480C).
MS analysis was performed on a 1 pglpL solution of DiazaCon. To permit the identification of impurities, the solution was infused directly into the atmospheric pressure chemical ionization source without any preliminary chromatographic separations. MS analysis gave the expected MHt base ion of m/z = 389 (Figure 2 ). MSMS analysis of the base ion resulted in m/z = 344, which is consistent with the loss of the positively charged dimethyl amine moiety. MSIMSMS analysis of the 344 ion gave a base peak of m/z = 316, which is consistent with the loss of HzCCH,.
Neither C-13 nor proton NMR completely resolved all 25 carbons or 46 hydrogens, respectively (Figure 1) . However, all discernible data were consistent with the structure of DiazaCon. Carbon assignments were C-3, 72 ppm; C-5, 144 ppm; C-6, 123 ppm; C-l7,76 ppm; C-22,56 ppm; C-23 51 ppm; C-24,55 ppm; C-26127,43 ppm; C-21.42 ppm. Signals for the remaining 15 carbons were located between 41 and 10 ppm. Proton NMR results were H-3 (IH), 3.25 ppm; H-6 (1H), 5.2 ppm; H-17/22/24 (5H), 2.8 ppm; H-18/19 (6H) 0.9 ppm; H-20 (lH), 3.2 ppm. The hydroxyl H was undiscernible as it would be expected to be obscured by the solvent peak. Remaining hydrogens were located between 2.2 and 0.9 ppm. These locations are consistent with the expected results. Peak assignments versus noise permitted a maximum of 10% undetected impurities in the carbon spectra and 1-2% in the proton spectra. The NMR analyses indicate the presence of no impurities greater than 1-2% in the technical standard. Analysis of the standard by elemental analysis, melting point analysis, MS, and NMR fail to indicate the presence of any impurities in the DiazaCon analytical standard.
Chromatograms of fortified and blank sera and quail feed are shown in Figure 3 . Due to the consistent slope of the baseline, integration of diazacholesterol peak area was easily accomplished. Under the specified conditions, the retention time for diazacholesterol is approximately 7.5 min for quail feed extracts and 8.0 min for sera extracts. The MLOD for the sera, based on the chromatographic response from 40 ppm fortified sample, was 13 ppm. The MLOD for feed, based on the chromatographic response from a 500 ppm fortified sample was approximately 14 ppm. Response linearity (chromatographic response versus concentration) for DiazaCon in the LC system was excellent, as rZ was >0.995 ( Figure 4 ). For the log-log plots, slopes ranged from 0.998 to 1.02 and were not significantly different from 1.0, indicating a proportional response.
Data for recoveries of DiazaCon from both sera and quail feed fortified at several levels are shown in Table 1 . Recoveries from sera ranged from 69.3% at 35 ppm to 95.2% at 1200 ppm. The fortification range was more narrow for quail feed than sera as the feed was prepared at a target concentration of 1000 ppm (0.10%). Feed was fortified at 50 and 150% of this target concentration. Mean recoveries ranged from 89.1 to 91.0%. For both matrixes, variation decreased with increasing fortification levels. However, variation was acceptable at all foaification levels as the coefficient of variation (CV) never exceeded 4.5%.
This method was used to confirm the concentration of DiazaCon in 39 quail feed and 60 quail sera samples. With each set of 10 samples, a blank and fortified quality control sample were also analyzed. No chromatographic interferences were noted in any of the blank extract.?. Recoveries for the fortified QC samples analyzed concurrently with study samples are presented in Table 2 . For sera, the mean recovery for the 150 ppm QC samples was 80.2%, while the recovery of the 35 ppm QC sample was 75.0%. The mean recovery of the 1000 ppm feed samples was nearly identical at 80.4%. While QC recoveries for both matrixes were similar, the variability for the sera samples was less than half that observed for the quail feed.
The corrected mean DiazaCon concentration in the medicated feed was 1085 ppm. While this mean concentration was within 10% of the target concentration, the CV was 29%. This suggests that the medicated feeds should be prepared more carefully andlor the formulation procedure could be improved. As the baits were prepared under field conditions, the precision could likely be improved by preparing the baits in an analytical or formulation lab. The medicated feed then could be subsequently transported to the required site. No DiazaCon residues were detected in the sera samples in spite of the fact that the dose was efficacious (number of eggs laid decreased by 75 to 90%). The sera residue data suggest that the blood does not harbor significant residues of DiazaCon. This method proved sufficiently rugged to c o n f i i the concentration of DiazaCon in medicated feed and to establish that DiazaCon has excellent potential as a contraceptive for nonlethal control of pest bird populations.
